Samuel Kintz
Fundador en ENLIVEN THERAPEUTICS, INC. .
Fortuna: 21 M $ al 30/04/2024
Perfil
Samuel S.
Kintz is the founder of Enliven Therapeutics, Inc. (founded in 2019) and currently holds the titles of President, Chief Executive Officer & Director.
Mr. Kintz's education history includes an undergraduate degree from Stanford University and an MBA from Stanford Graduate School of Business.
Mr. Kintz is also the founder of Enliven Therapeutics, Inc...
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
25/04/2024 | 1 264 587 ( 2.70% ) | 21 M $ | 30/04/2024 |
Cargos activos de Samuel Kintz
Empresas | Cargo | Inicio |
---|---|---|
ENLIVEN THERAPEUTICS, INC. | Fundador | 01/06/2019 |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Fundador | - |
Formación de Samuel Kintz.
Stanford University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ENLIVEN THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Samuel Kintz